Pretreatment MR-based radiomics in patients with glioblastoma: A systematic review and meta-analysis of prognostic endpoints
European Journal of Radiology · 2023-11 · 168 · 111130
DOI: 10.1016/j.ejrad.2023.111130 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Radiology, 2023-11. Verfasst von Yangsean Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea; Department of Radiology…. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
PURPOSE: Recent studies have shown promise of MR-based radiomics in predicting the survival of patients with untreated glioblastoma. This study aimed to comprehensively collate evidence to assess the prognostic value of radiomics in glioblastoma. METHODS: PubMed-MEDLINE, Embase, and Web of Science were searched to find original articles investigating the prognostic value of MR-based radiomics in glioblastoma published up to July 14, 2023. Concordance indexes (C-indexes) and Cox proportional hazards ratios (HRs) of overall survival (OS) and progression-free survival (PFS) were pooled via random-effects modeling. For studies aimed at classifying long-term and short-term PFS, a hierarchical regression model was used to calculate pooled sensitivity and specificity. Between-study heterogeneity was assessed using the Higgin inconsistency index (I2). Subgroup regression analysis was performed to find potential factors contributing to heterogeneity. Publication bias was assessed via funnel plots and the Egger test. RESULTS: Among 1371 abstracts, 18 and 17 studies were included for qualitative and quantitative data synthesis, respectively. Respective pooled C-indexes and HRs for OS were 0.65 (95 % confidence interval [CI], 0.58-0.72) and 2.88 (95 % CI, 2.28-3.64), whereas those for PFS were 0.61 (95 % CI, 0.55-0.66) and 2.78 (95 % CI, 1.91-4.03). Among 4 studies that predicted short-term PFS, the pooled sensitivity and specificity were 0.77 (95 % CI, 0.58-0.89) and 0.60 (95 % CI, 0.45-0.73), respectively. There was a substantial between-study heterogeneity among studies with the survival endpoint of OS C-index (n = 9, I2 = 83.8 %). Publication bias was not observed overall. CONCLUSION: Pretreatment MR-based radiomics provided modest prognostic value in both OS and PFS in patients with glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea; Department of Radiology and Research Institute of Radiology, University of Ulsan College of M…
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea.
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea. Electronic address: ahn-kj@catholic.ac.kr.
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Choi, Y., Jang, J., Kim, B. S., & Ahn, K. J. (2023). Pretreatment MR-based radiomics in patients with glioblastoma: A systematic review and meta-analysis of prognostic endpoints. European Journal of Radiology, 168, 111130. https://doi.org/10.1016/j.ejrad.2023.111130
Vancouver
Choi Y, Jang J, Kim BS, Ahn KJ. Pretreatment MR-based radiomics in patients with glioblastoma: A systematic review and meta-analysis of prognostic endpoints. European Journal of Radiology. 2023;168:111130. doi:10.1016/j.ejrad.2023.111130
BibTeX
@article{Choi2023,
author = {Choi, Yangsean and Jang, Jinhee and Kim, Bum-Soo and Ahn, Kook-Jin},
title = {Pretreatment MR-based radiomics in patients with glioblastoma: A systematic review and meta-analysis of prognostic endpoints},
journal = {European Journal of Radiology},
year = {2023},
volume = {168},
pages = {111130},
doi = {10.1016/j.ejrad.2023.111130}
}
EUVIMED